Efficacy and Safety of Low-dose IL-2 in Patients With SLE: a Multicenter, Randomised, Placebo-controlled Trial
Clinical trial NCT04077684 · COMPLETED
Trial details
- NCT number
- NCT04077684
- Sponsor
- Peking University People's Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-10
- Primary completion
- 2024-03-07
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.